Ozempic

Thursday

Max Pemberton

Could Ozempic bankrupt the NHS?

The NHS spends around £6.5 billion every year treating obesity. People who are overweight cost the health service twice as much as those who maintain a healthy weight. Half of all cancer cases are linked to obesity and being severely overweight significantly increases the risk of other conditions, such as diabetes, strokes and heart attacks. No public health campaign or intervention has ever worked. Obesity rates have nearly doubled in the UK since the 1990s. More than 60 per cent of adults are overweight. It’s hoped that weight-loss injections, known as GLP-1 agonists – semaglutide (also known as Wegovy or Ozempic) and the more recent market entry tirzepatide (Mounjaro) –

Wednesday

Martin Vander Weyer

Jeremy Hunt should stick to sensible pledges – it’s too late for big moves

Imagine you’re Chancellor Jeremy Hunt, drafting your Autumn Statement for delivery in three weeks’ time. Bookies’ odds for a Tory general election win have moved out to six-to-one (against Labour’s dead-cert one-to-seven) following by-election wipe-outs. The Lib Dems look set to nab your South West Surrey seat if you don’t stand down anyway. And you can’t give your back-benches red-meat tax cuts because public borrowing for this year could run £30 billion higher than forecast. Releasing the pension ‘triple lock’ to save money would alienate older Tories. Inheritance tax giveaways that might please them would be campaign gold for Labour. A stamp duty cut would do nothing for floating-vote home-buyers facing